BEATBio Lands $2,500,000 Seed Financing Round

  • Feed Type
  • Date
    4/17/2013
  • Company Name
    BEATBio
  • Mailing Address
    Undisclosed Seattle, WA 98101
  • Company Description
    BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bio’s first product is based on a fundamental discovery in cardiac muscle contraction and the development of a novel GeneTherapy to improve cardiac performance in the setting of heart failure.
  • Website
    http://www.beatbiotherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,500,000
  • Transaction Round
    Seed
  • Proceeds Purposes
    The proceeds will be used to move BEATBio’s lead gene therapy product into clinical development.
  • M&A Terms
  • Venture Investor
    CET Capital Partners
  • Venture Investor
    W Fund

By posting a comment, you agree to our terms and conditions.